Johnson & Johnson (JNJ) Operating Margin Growth (5y) (2014 - 2026)

Johnson & Johnson (JNJ) Operating Margin Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -310.00
Dec 28, 2025 4,544.00
Sep 28, 2025 194.00
Jun 29, 2025 620.00
Mar 30, 2025 26.00
Dec 29, 2024 -374.00
Sep 29, 2024 -566.00
Jun 30, 2024 279.00
Mar 31, 2024 120.00
Dec 31, 2023 6,855.00
Oct 1, 2023 -23.00
Jul 2, 2023 135.00
Apr 2, 2023 -74.00
Jan 1, 2023 3,351.00
Oct 2, 2022 345.00
Jul 3, 2022 -884.00
Apr 3, 2022 -825.00
Oct 3, 2021 -130.00
Jul 4, 2021 -351.00
Apr 4, 2021 -86.00